LINK: https://bswhealth.webex.com/bswhealth/j.php?MTID=m38117495c8101e8140b0ede892885d75

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Know the three key histopathologic patterns of DAH (2) Understand the literature regarding therapy for capillaritis related DAH (3) Highlight important components of the evaluation of DAH

FACULTY DISCLOSURE:  Yosafe Wakwaya, MD, has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE:  Susan Mathai, MD, is a consultant for Natera, Inc, Mount Sinai School of Medicine as an independent contractor, CU Innovations and Geven P15.as a patent Beneficiary and  Cumberland; Foresee; Department of Defense; NIH as a site principal investigator and clinical trial and research study.  Adam Hayek, DO has disclosed he is a researcher for Foresee Pharmaceuticals, Co., Ltd, Jansen-Sirukumab, Mesoblast Inc., Regeneron, and Kinevant Sciences GmbHand.  Ginger Tsai-Nguyen, MD, has no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact William Wells at William.Wells@bswhealth.org